Venetoclax-Azacitidine in Combination With Chidamide and CAG in Fit Older Patients With Acute Myeloid Leukaemia

Clinical trial NCT07514936 · RECRUITING

Trial details

NCT number: NCT07514936
Sponsor: Chinese PLA General Hospital
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Newly Diagnosed Acute Myeloid Leukemia (AML)Elderly Patients

Start date: 2024-11-18
Primary completion: 2027-09-30
Enrollment: 120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.